TAKING dietary supplements during breast cancer treatment could do more harm than good, Australian Medication Safety Services, Principal Consultant, Dr Chris Alderman, warns.
Citing data published in the Journal of Clinical Oncology, Alderman warned the use of antioxidant supplements including vitamins A, C and E, both before and during treatment were associated with an increased hazard of recurrence, while the consumption of iron and vitamin B12 before and during chemotherapy was "significantly associated with poorer disease-free survival".
The above article was sent to subscribers in Pharmacy Daily's issue from 22 Jan 20
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Jan 20
